Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Iber C, Redline S, Kaplan Gilpin AM, et al. "Polysomnography performed in the unattended home versus the attended laboratory setting--Sleep Heart Health Study methodology." Sleep. 2004;27(3):536-40.
Ibrahim-Verbaas CA, Fornage M, Bis JC, et al. "Predicting stroke through genetic risk functions: the CHARGE Risk Score Project." Stroke. 2014;45(2):403-12.
M Ikram A, Seshadri S, Bis JC, et al. "Genomewide association studies of stroke." N Engl J Med. 2009;360(17):1718-28.
M Ikram K, Mitchell P, Klein R, A Sharrett R, Couper DJ, Wong TY. "Age-related macular degeneration and long-term risk of stroke subtypes." Stroke. 2012;43(6):1681-3.
Ilkhanoff L, Arking DE, Lemaitre RN, et al. "A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans." J Cardiovasc Electrophysiol. 2014;25(11):1150-7.
Imamura F, Lemaitre RN, King IB, et al. "Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts." Circulation. 2013;127(14):1512-21, 1521e1-18.
Imboden M, Bouzigon E, Curjuric I, et al. "Genome-wide association study of lung function decline in adults with and without asthma." J Allergy Clin Immunol. 2012;129(5):1218-28.
Inciardi RM, Claggett B, Minamisawa M, et al. "Association of Left Atrial Structure and Function With Heart Failure in Older Adults." J Am Coll Cardiol. 2022;79(16):1549-1561.
Inciardi RM, Claggett B, Gupta DK, et al. "Cardiac Structure and Function and Diabetes-Related Risk of Death or Heart Failure in Older Adults." J Am Heart Assoc. 2022;11(6):e022308.
Inker LA, Grams ME, Levey AS, et al. "Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium." Am J Kidney Dis. 2019;73(2):206-217.
Inker LA, Coresh JJ, Sang Y, et al. "Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis." Clin J Am Soc Nephrol. 2017;12(1):69-78.
"Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis." Lancet Diabetes Endocrinol. 2015;3(4):243-53.
Ehret GB, Munroe PB, Rice KM, et al. "Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk." Nature. 2011;478(7367):103-9.
"Convergent genetic and expression data implicate immunity in Alzheimer's disease." Alzheimers Dement. 2015;11(6):658-71.
Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. "Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities." Ann Epidemiol. 1996;6(4):331-40.
Iribarren C, Sempos CT, Eckfeldt JH, Folsom AR. "Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis Risk in Communities." Atherosclerosis. 1998;139(1):189-95.
Iribarren C, Folsom AR, Jacobs DR, Gross MD, Belcher JD, Eckfeldt JH. "Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities." Arterioscler Thromb Vasc Biol. 1997;17(6):1171-7.
Irvin MR, Sitlani CM, Noordam R, et al. "Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry." Pharmacogenomics J. 2019;19(1):97-108.
Irvin MR, Sitlani CM, Floyd JS, et al. "Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group." Am J Hypertens. 2019;32(12):1146-1153.
Ishigami J, Cowan LT, Demmer RT, Grams ME, Lutsey PL, Coresh JJ. "Hospitalization With Major Infection and Incidence of End-Stage Renal Disease: The Atherosclerosis Risk in Communities (ARIC) Study." Mayo Clin Proc. 2020;95(9):1928-1939.
Ishigami J, Honda Y, Karger AB, et al. "18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study." Eur J Endocrinol. 2022;187(1):39-47.
Ishigami J, Padula WV, Grams ME, et al. "Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States." Am J Kidney Dis. 2019;74(1):23-35.
Ishigami J, Karger AB, Lutsey PL, Coresh J, Matsushita K. "STABILITY OF SERUM BONE-MINERAL, KIDNEY, AND CARDIAC BIOMARKERS AFTER A FREEZE-THAW CYCLE: THE ARIC STUDY." Am J Epidemiol. 2022;191(3):534-537.
Ishigami J, Grams ME, Naik RP, Coresh JJ. "Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study." Clin J Am Soc Nephrol. 2016;11(10):1735-1743.
Ishigami J, Cowan LT, Demmer RT, et al. "Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome." J Am Soc Nephrol. 2020;31(2):405-414.
Ishigami J, Grams ME, Michos ED, Lutsey PL, Matsushita K. "25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up." Kidney Int Rep. 2021;6(5):1299-1308.
Ishigami J, Sumida K, Grams ME, et al. "CKD and Risk of Incident Hospitalization With Clostridioides difficile Infection: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2022;80(2):297-299.
Ishigami J, Grams ME, Naik RP, et al. "Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study." J Am Heart Assoc. 2018;7(2).
Ishigami J, Mathews L, Hishida M, et al. "Echocardiographic measures and subsequent decline in kidney function in older adults: the Atherosclerosis Risk in Communities Study." Eur Heart J Cardiovasc Imaging. 2021.
Ishigami J, Honda Y, Karger AB, et al. "Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study." Mayo Clin Proc Innov Qual Outcomes. 2022;6(3):209-217.
Ishigami J, Jaar BG, Rebholz CM, et al. "Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study." J Clin Endocrinol Metab. 2017;102(12):4648-4657.
Ishigami J, Kim Y, Sang Y, et al. "High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2021;67(1):298-307.
Ishigami J, Hoogeveen RC, Ballantyne CM, Folsom AR, Coresh JJ, Selvin E. "Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2019;188(12):2146-2155.
Islek D, Alonso A, Rosamond W, et al. "Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study." Am Heart J. 2022;253:67-75.
Iso H, Harada S, Shimamoto T, et al. "Polymorphism of the apolipoprotein B gene and blood lipid concentrations in Japanese and Caucasian population samples." Atherosclerosis. 1996;126(2):233-41.
Iso H, Koike KA, Folsom AR, et al. "Lipoprotein(a) and its correlates in Japanese and U.S. population samples." Ann Epidemiol. 1996;6(4):324-30.
Iso H, Folsom AR, Sato S, et al. "Plasma fibrinogen and its correlates in Japanese and US population samples." Arterioscler Thromb. 1993;13(6):783-90.
Iso H, Folsom AR, Koike KA, et al. "Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women." Thromb Haemost. 1993;70(3):475-80.